Vir Biotechnology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
49.50
|
|
Average Rating
|
3.70
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.21
|
1.30
|
1.51
|
719.05%
|
|
2022-06-30
|
0.11
|
-0.58
|
-0.69
|
-627.27%
|
|
2022-03-31
|
3.78
|
3.85
|
0.07
|
1.85%
|
|
2021-12-31
|
3.04
|
3.92
|
0.88
|
28.95%
|
|
2021-09-30
|
0.02
|
0.82
|
0.80
|
4000.00%
|
|
2021-06-30
|
-0.48
|
0.46
|
0.94
|
195.83%
|
|
2021-03-31
|
-0.21
|
-1.32
|
-1.11
|
-528.57%
|
|
2020-12-31
|
-0.70
|
-0.83
|
-0.13
|
-18.57%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
4.57
|
|
2021-12-31
|
3.88
|
|
2020-12-31
|
-2.48
|
|
2019-12-31
|
-6.00
|